169 related articles for article (PubMed ID: 3393491)
1. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
[TBL] [Abstract][Full Text] [Related]
2. Role of prolactin in modulating the effects of tamoxifen on growth of the Dunning R3327 rat prostate adenocarcinoma.
Sylvester PW; Ip MM
Prostate; 1987; 10(1):57-67. PubMed ID: 3822918
[TBL] [Abstract][Full Text] [Related]
3. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma.
Landström M; Bergh A; Tomic R; Damber JE
Prostate; 1990; 17(1):57-68. PubMed ID: 1696714
[TBL] [Abstract][Full Text] [Related]
4. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A
Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
[TBL] [Abstract][Full Text] [Related]
5. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
Ip MM; Milholland RJ; Rosen F
Cancer Res; 1980 Jul; 40(7):2188-93. PubMed ID: 7388787
[TBL] [Abstract][Full Text] [Related]
6. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
Damber JE; Bergh A; Landström M; Tomić R
J Urol; 1991 Jun; 145(6):1283-7. PubMed ID: 1827847
[TBL] [Abstract][Full Text] [Related]
7. Estrogen treatment of Dunning tumors in castrated rats: qualitative and quantitative morphology.
Landström M; Bergh A; Thornell LE; Virtanen I; Damber JE
Prostate; 1992; 20(3):199-211. PubMed ID: 1574467
[TBL] [Abstract][Full Text] [Related]
8. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R
J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
[TBL] [Abstract][Full Text] [Related]
9. Dunning R3327-G prostate carcinoma of the rat: an appropriate model for drug evaluation.
Kager M; Spruss T; Schneider MR; von Angerer E
J Cancer Res Clin Oncol; 1992; 118(5):334-8. PubMed ID: 1583064
[TBL] [Abstract][Full Text] [Related]
10. Effect of zindoxifene on experimental prostatic tumours of the rat.
Schneider MR; Schiller CD; Humm A; von Angerer E
J Cancer Res Clin Oncol; 1991; 117(1):33-6. PubMed ID: 1997466
[TBL] [Abstract][Full Text] [Related]
11. Estrogen induces apoptosis in a rat prostatic adenocarcinoma: association with an increased expression of TGF-beta 1 and its type-I and type-II receptors.
Landström M; Eklöv S; Colosetti P; Nilsson S; Damber JE; Bergh A; Funa K
Int J Cancer; 1996 Aug; 67(4):573-9. PubMed ID: 8759618
[TBL] [Abstract][Full Text] [Related]
12. Effects of 6-methylene progesterone on growth, morphology, and blood flow of the Dunning R3327 prostatic adenocarcinoma.
Damber JE; Bergh A; Daehlin L; Petrow V; Landström M
Prostate; 1992; 20(3):187-97. PubMed ID: 1574466
[TBL] [Abstract][Full Text] [Related]
13. Antitumoral effects of R 75251 on the growth of transplantable R3327 prostatic adenocarcinoma in rats.
Van Ginckel R; De Coster R; Wouters W; Vanherck W; van der Veer R; Goeminne N; Jagers E; Van Cauteren H; Wouters L; Distelmans W
Prostate; 1990; 16(4):313-23. PubMed ID: 2371176
[TBL] [Abstract][Full Text] [Related]
14. Effect of the preestrogen 4-androstene-3,17-dion-19-al on the Dunning R3327 prostatic adenocarcinoma.
Marks TA; Petrow V
Cancer Res; 1983 Aug; 43(8):3687-90. PubMed ID: 6861138
[TBL] [Abstract][Full Text] [Related]
15. Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
Landström M; Tomić R; Damber JE
Eur Urol; 1987; 13(3):203-6. PubMed ID: 2956111
[TBL] [Abstract][Full Text] [Related]
16. Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.
Daehlin L; Bergh A; Damber JE
Urol Res; 1987; 15(3):169-72. PubMed ID: 3629752
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity.
Schneider MR; Hartmann RW; Sinowatz F; Amselgruber W
J Cancer Res Clin Oncol; 1986; 112(3):258-65. PubMed ID: 2946698
[TBL] [Abstract][Full Text] [Related]
18. Effects of tobacco smoke on tumor growth and radiation response of dunning R3327 prostate adenocarcinoma in rats.
Johansson S; Landström M; Bjermer L; Henriksson R
Prostate; 2000 Mar; 42(4):253-9. PubMed ID: 10679754
[TBL] [Abstract][Full Text] [Related]
19. Expression of transforming growth factor-beta 1 in rat ventral prostate and Dunning R3327 PAP prostate tumor after castration and estrogen treatment.
Lindström P; Bergh A; Holm I; Damber JE
Prostate; 1996 Oct; 29(4):209-18. PubMed ID: 8876704
[TBL] [Abstract][Full Text] [Related]
20. Castration rapidly results in a major reduction in epithelial cell numbers in the rat prostate, but not in the highly differentiated Dunning R3327 prostatic adenocarcinoma.
Westin P; Bergh A; Damber JE
Prostate; 1993; 22(1):65-74. PubMed ID: 8426839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
